048530 — iNtRON Biotechnology Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual income statement for iNtRON Biotechnology, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	45,433	29,308	14,007	9,585	6,418
Cost of Revenue
Gross Profit	26,533	21,772	9,658	5,843	3,737
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	29,559	19,230	15,480	18,621	11,655
Operating Profit	15,874	10,078	-1,473	-9,035	-5,238
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17,051	10,575	8,319	-10,837	-3,006
Provision for Income Taxes
Net Income After Taxes	14,948	9,728	5,712	-9,695	-2,591
Minority Interest
Net Income Before Extraordinary Items
Net Income	14,948	9,728	5,712	-9,695	-2,591
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	12,568	9,728	-12.3	-9,695	-2,591
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	363	290	0.892	-179	-91.3
Dividends per Share